Table 2.
Clinical characteristics of reported cases of synchronous gastric carcinoma and FL.
| References | Age (year) | Gender | Lymphoma | Gastric carcinoma | Chemotherapy regimens | OS (months) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diagnosis | Staging | Treatment | Diagnosis | Staging | Treatment | |||||
| Xue et al. (4) | 68 | Female | FL | IVB | Chemo | Gastric moderately differentiated adenocarcinoma | Not described |
Chemo | R-CHOP, 5-FU + L-OHP + VP-16 |
Not described |
| Present case | 61 | Male | FL (grade 3) |
IV | Chemo Radio |
Gastric tubular adenocarcinoma |
- | Chemo, Ope |
R-CHOP, R-GEMOX + S-1, R + S-1, Lenalidomide |
53 |
FL, follicular lymphoma; 5-FU, 5-fluorouracil; L-OHP, oxaliplatin; VP-16, etoposide; VCR, vincristine; DXM, dexamethasone; OS, overall survival.